Prospective Study
Copyright ©The Author(s) 2022.
World J Radiol. Jun 28, 2022; 14(6): 165-176
Published online Jun 28, 2022. doi: 10.4329/wjr.v14.i6.165
Table 3 Comparison of perioperative and pathological parameters between patients with and without clinically relevant postoperative pancreatic fistula
Parameter
CR-POPF, n = 18
No CR-POPF,n = 43
P value
Operative time in min, mean ± SD521.9 ± 123463.9 ± 101.20.275
Blood loss in mL, median (IQR)550 (350-725)475 (350-800)0.830
Intraoperative blood transfusion, n (%)6 (33.3)17 (39.5)0.775
Pancreatic texture, n (%)
Firm1 (5.6)20 (47.6)0.002
Soft17 (94.4)22 (52.4)
Pancreatic duct size in mm, mean ± SD2.8 ± 1.13.4 ± 1.60.169
Surgical approach, n (%)
Open9 (50)24 (55.8)
Laparoscopic6 (33.3)12 (27.9)
Robot assisted3 (16.7)7 (16.3)0.927
Delayed gastric emptying, n (%)15 (83.3)13 (30.2)< 0.001
Postpancreatectomy hemorrhage, n (%)3 (16.7)4 (9.3)0.662
Intra-abdominal abscess, n (%)9 (50)1 (2.3)< 0.001
Hospital stay in d, mean ± SD26.8 ± 13.99.6 ±.60.001
Pathology, n (%)
Malignant17 (94.4)35 (81.4)
Benign1 (5.6)8 (18.6)0.259
Fat fraction, n (%)
Absent 6 (33.3)20 (46.5)
Mild9 (50.0)17 (39.6)0.669
Moderate3 (16.7)6 (13.9)
Fibrosis score, n (%)
Weak16 (88.9)27 (62.8)
Heavy2 (11.1)16 (37.2)0.063